Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 585,960 | 685,579 | 702,412 | 480,523 |
| General And Administrative Expense | 585,960 | 685,579 | 702,412 | 480,523 |
| Other Operating Expenses | 807,037 | 1.6M | 505,173 | 245,125 |
| Operating Expense | 1.4M | 2.3M | 1.2M | 725,648 |
| Operating Income | -1.4M | -2.3M | -1.2M | -725,648 |
| EBIT | -1.4M | -2.3M | -1.2M | -725,648 |
| Other Income Expense | 129,848 | 220,186 | 205,074 | 36,944 |
| Other Non Operating Income Expenses | 145,924 | 229,475 | 214,675 | 39,921 |
| Special Income Charges | -- | -- | -- | 0.00 |
| Gain On Sale Of Security | -16,076 | -9,289 | -9,601 | -2,977 |
| Pretax Income | -1.3M | -2.1M | -1.0M | -688,704 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -1.3M | -2.1M | -1.0M | -688,704 |
| Net Income From Continuing Operation Net Minority Interest | -1.3M | -2.1M | -1.0M | -688,704 |
| Net Income Including Noncontrolling Interests | -1.3M | -2.1M | -1.0M | -688,704 |
| Net Income Common Stockholders | -1.3M | -2.1M | -1.0M | -688,704 |
| Net Income | -1.3M | -2.1M | -1.0M | -688,704 |
| EBITDA | -1.4M | -2.3M | -1.2M | -725,648 |
| Normalized EBITDA | -1.4M | -2.3M | -1.2M | -722,671 |
| Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 |
| Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 |
| Basic Average Shares | 203.9M | 166.7M | 139.7M | 124.0M |
| Diluted Average Shares | 203.9M | 166.7M | 139.7M | 124.0M |
| Total Unusual Items | -16,076 | -9,289 | -9,601 | -2,977 |
| Total Unusual Items Excluding Goodwill | -16,076 | -9,289 | -9,601 | -2,977 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -1.2M | -2.1M | -992,910 | -685,727 |
| Diluted NI Availto Com Stockholders | -1.3M | -2.1M | -1.0M | -688,704 |
| Gain On Sale Of Ppe | -- | -- | -- | 0.00 |
| Net Income Continuous Operations | -1.3M | -2.1M | -1.0M | -688,704 |
| Other Gand A | 555,904 | 481,876 | 657,291 | 256,070 |
| Rent And Landing Fees | 30,056 | 52,788 | 39,587 | 26,353 |
| Rent Expense Supplemental | 30,056 | 52,788 | 39,587 | 26,353 |
| Salaries And Wages | 0.00 | 150,915 | 5,534 | 198,100 |
| Total Expenses | 1.4M | 2.3M | 1.2M | 725,648 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 188,505 | 408,962 | 816,604 | 864,584 |
| Cash Cash Equivalents And Short Term Investments | 188,505 | 408,962 | 816,604 | 864,584 |
| Cash Financial | -- | -- | 816,604 | 864,584 |
| Accounts Receivable | -- | -- | 86,014 | -- |
| Receivables | 105,802 | 96,217 | 86,014 | 19,813 |
| Prepaid Assets | 71,036 | 11,427 | 12,525 | 10,400 |
| Current Assets | 365,343 | 516,606 | 915,143 | 894,797 |
| Net PPE | -- | 9.0M | 8.0M | 7.1M |
| Total Non Current Assets | 33,750 | 33,750 | 33,750 | 7.2M |
| Total Assets | 399,093 | 550,356 | 948,893 | 8.0M |
| Payables And Accrued Expenses | 1.3M | 1.5M | 1.1M | 599,993 |
| Other Current Liabilities | 232,400 | 145,924 | 181,176 | 211,486 |
| Current Liabilities | 1.6M | 1.6M | 1.3M | 821,479 |
| Total Non Current Liabilities Net Minority Interest | 30,000 | 30,000 | 30,000 | 30,000 |
| Total Liabilities Net Minority Interest | 1.6M | 1.7M | 1.3M | 851,479 |
| Common Stock | 37.3M | 36.4M | 35.6M | 34.6M |
| Capital Stock | 37.3M | 36.4M | 35.6M | 34.6M |
| Retained Earnings | -39.9M | -38.7M | -36.9M | -28.3M |
| Common Stock Equity | -1.2M | -1.1M | -347,345 | 7.2M |
| Stockholders Equity | -1.2M | -1.1M | -347,345 | 7.2M |
| Total Equity Gross Minority Interest | -1.2M | -1.1M | -347,345 | 7.2M |
| Total Capitalization | -1.2M | -1.1M | -347,345 | 7.2M |
| Net Tangible Assets | -1.2M | -1.1M | -347,345 | 7.2M |
| Tangible Book Value | -1.2M | -1.1M | -347,345 | 7.2M |
| Working Capital | -1.2M | -1.1M | -351,095 | 73,318 |
| Invested Capital | -1.2M | -1.1M | -347,345 | 7.2M |
| Share Issued | 242.3M | 190.0M | 154.5M | 129.3M |
| Ordinary Shares Number | 242.3M | 190.0M | 154.5M | 129.3M |
| Current Provisions | 10,000 | 10,000 | 10,000 | 10,000 |
| Long Term Provisions | 30,000 | 30,000 | 30,000 | 30,000 |
| Non Current Prepaid Assets | 33,750 | 33,750 | 33,750 | 5,000 |
| Other Equity Interest | 1.4M | 1.2M | 888,614 | 879,652 |
| Taxes Receivable | 105,802 | 96,217 | 86,014 | 19,813 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -1.4M | -1.6M | -833,659 | -267,012 |
| Cash Flow From Continuing Operating Activities | -1.4M | -1.6M | -833,659 | -267,012 |
| Stock Based Compensation | 0.00 | 150,915 | 5,534 | 198,100 |
| Change In Working Capital | -13,792 | 574,323 | 368,392 | 260,536 |
| Change In Receivables | -9,585 | -10,203 | -62,754 | -13,277 |
| Change In Payables And Accrued Expense | 55,402 | 583,428 | 462,021 | 273,391 |
| Other Non Cash Items | -145,924 | -227,275 | -214,675 | -39,921 |
| Capital Expenditure | -- | -1.0M | -881,335 | -357,783 |
| Purchase Of PPE | -- | -1.0M | -881,335 | -357,783 |
| Net PPE Purchase And Sale | -- | -1.0M | -881,335 | -357,783 |
| Investing Cash Flow | -- | -1.0M | -820,099 | -321,281 |
| Cash Flow From Continuing Investing Activities | -- | -1.0M | -820,099 | -321,281 |
| Issuance Of Capital Stock | 1.3M | 1.3M | 1.7M | 900,000 |
| Net Common Stock Issuance | 1.3M | 1.3M | 1.7M | 900,000 |
| Financing Cash Flow | 1.2M | 1.2M | 1.6M | 888,826 |
| Cash Flow From Continuing Financing Activities | 1.2M | 1.2M | 1.6M | 888,826 |
| Effect Of Exchange Rate Changes | -- | -- | -- | 0.00 |
| Changes In Cash | -220,457 | -407,642 | -47,980 | 300,533 |
| Beginning Cash Position | 408,962 | 816,604 | 864,584 | 564,051 |
| End Cash Position | 188,505 | 408,962 | 816,604 | 864,584 |
| Free Cash Flow | -1.4M | -1.6M | -1.7M | -624,795 |
| Change In Prepaid Assets | -59,609 | 1,098 | -30,875 | 422.00 |
| Common Stock Issuance | 1.3M | 1.3M | 1.7M | 900,000 |
| Gain Loss On Sale Of PPE | -- | -- | -- | 0.00 |
| Net Foreign Currency Exchange Gain Loss | 16,076 | 9,289 | 9,601 | 2,977 |
| Net Income From Continuing Operations | -1.3M | -2.1M | -1.0M | -688,704 |
| Net Other Financing Charges | -109,343 | -141,877 | -82,220 | -11,174 |
| Net Other Investing Changes | -- | 973.00 | 61,236 | 36,502 |
| Operating Gains Losses | 16,076 | 9,289 | 9,601 | 2,977 |
| Proceeds From Stock Option Exercised | -- | -- | -- | 0.00 |
| Sale Of PPE | -- | -- | -- | 0.00 |